Private company
Genelux Corporation
Logo: genelux.com3
Biopharmaceutical company
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- HeadquartersSan Diego1
- Websitewww.genelux.com
See how the biggest companies compare on our leaderboards
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity.2
Timeline
- 2001Founded Founded1
Links
- Websitewww.genelux.com1
- WikipediaGenelux Corporation
- WikidataQ25326575
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataGenelux Corporation on Wikidata
- 2WikipediaGenelux Corporation on Wikipedia
- 3Company websiteGenelux Corporation logo